Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Dr. Leonard G. Horowitz Issues Legal Notice Urging Investigation into COVID-19 Research Origins and Vaccine Technologies





Health Freedom Advocate Submits Legal Notice to HHS, NIH, and DOJ Calling for Investigation into COVID-19 Origins and Related Research Practices

LAS VEGAS, NV, June 10, 2025 /24-7PressRelease/ -- Dr. Leonard G. Horowitz, a Harvard-trained researcher in emerging diseases and Editor-in-Chief of Medical Veritas International Inc., has issued a formal legal "Notice and Demand" addressed to U.S. Health and Human Services Secretary Robert F. Kennedy Jr., National Institutes of Health Director Dr. Jay Bhattacharya, and U.S. Attorney General Pam Bondi. The notice calls for further examination of the origins of COVID-19 and the technologies used in response efforts, including vaccine delivery systems.

According to Dr. Horowitz, the notice outlines concerns about the possible role of international gain-of-function research in the emergence of COVID-19, referencing collaborative efforts between U.S. and Chinese institutions. It highlights figures such as Dr. Ralph Baric (UNC), Dr. Charles Lieber (Harvard), Dr. Robert Langer (MIT), and former NIAID Director Dr. Anthony Fauci as individuals of interest for review. The document raises questions about whether certain research and public health responses warrant independent investigation.

Among the topics addressed in the notice are the use of novel nanotechnologies in vaccine delivery—including mRNA platforms and hydrogel components. Dr. Horowitz asserts that some of these systems may be linked to adverse health outcomes, including neurological, cardiovascular, and immunological complications, and recommends further scientific review of these claims.

The document also critiques the U.S. government's handling of related oversight, including a recent Executive Order on biological research safety. Dr. Horowitz contends that current federal guidelines may not go far enough in addressing risks from domestic programs.

"This notice is meant to encourage transparency, accountability, and a science-based review of evidence," said Dr. Horowitz. "We believe the public deserves a fair and open discussion about the origins of COVID-19, the technologies used to address it, and the regulatory processes involved."

Medical Veritas International Inc., a nonprofit organization, has made the notice, supporting exhibits, and a summary video available to the public at MedicalVeritas.org. Dr. Horowitz, author of the book Emerging Viruses: AIDS & Ebola—Nature, Accident or Intentional?, invites scientists, policymakers, and independent media to evaluate the materials and contribute to a constructive, fact-based dialogue.

For media inquiries, please contact: Dr. Leonard G. Horowitz
Editor-in-Chief, Medical Veritas International Inc.
Email: editor@medicalveritas.org
Phone: (310) 877-3002

Medical Veritas International Inc. is a 501(c)(3) nonprofit dedicated to advancing public health by exposing censored truths about emerging diseases and Big Pharma's misconduct. The organization publishes peer-reviewed science and advocates for transparency in medicine and governance.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.